Biotechnology Stocks : Kurt Von Emster – Franklin Advisers Inc
KURT VON EMSTER joined MPM Capital, LP, in November 2000 to extend their
healthcare investment presence into the public markets. He is a General
Partner of the MPM BioEquities Fund and manages several funds for MPM
Advisors. He spent 11 years with Franklin Templeton Group as a Vice
President and Portfolio Manager. At Franklin, Mr. von Emster managed
over $2 billion in health and biotech funds, including the Franklin
Biotechnology Discovery Fund and the Franklin Global Health Care Fund.
Mr. von Emster holds the Chartered Financial Analyst designation, is a
member of the Association for Investment Management and Research, and is
a member of the Security Analysts of San Francisco. Mr. von Emster
earned a degree from the University of California Santa Barbara in
Business and Economics. Profile
TWST: What has been most striking about the performance of the
biotechnology stocks over the past six months or so?
Mr. von Emster: The immense volatility we've had is a bit of a surprise